mRNA Related Raw Materials
Shop By
-
Cytidine 5'-monophosphateCas#: 63-37-6 Compound CID: 6131Formula: C9H14N3O8P Molecular Weight: 323.2IUPAC Name: [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphateSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)OInChIKey: IERHLVCPSMICTF-XVFCMESISA-NInChI: InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1Synonyms: CMP | 5'-CMP | CYTIDINE-5''-MONOPHOSPHATE | Cytidine-5'-monophosphate | FN5 | Cytidine 5'-phosphoric acid | EINECS 20...
-
ATP Trisodium salt SolutionCas#: 56-65-5(free acid)Formula: C10H14N5Na3O13P3 Molecular Weight: 573.13
-
ATP Trisodium salt SolutionCas#: 56-65-5(free acid)Formula: C10H14N5Na3O13P3 Molecular Weight: 573.13
-
CTP Trisodium salt SolutionCas#: 65-47-4(acid form)Formula: C9H14N3Na3O14P3 Molecular Weight: 549.10
-
GTP Trisodium salt SolutionCas#: 36051-31-7 Compound CID: 135445727Formula: C10H13N5Na3O14P3 Molecular Weight: 589.13IUPAC Name: trisodium;[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] phosphateSMILES: C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)([O-])OP(=O)([O-])[O-])O)O)N=C(NC2=O)N.[Na+].[Na+].[Na+]InChIKey: KZRMTEVIDYXWQW-CYCLDIHTSA-KInChI: InChI=1S/C10H16N5O14P3.3Na/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21;;;/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18);;;/q;3*+1/p-3/t3-,5-,6-,9-;;;/m1.../s1Synonyms: Guanosine 5'-triphosphate sodium salt hydrate, >=95% (HPLC) | trisodium;[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-...
-
GTP Trisodium salt SolutionCas#: 36051-31-7 Compound CID: 135445727Formula: C10H13N5Na3O14P3 Molecular Weight: 589.13IUPAC Name: trisodium;[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] phosphateSMILES: C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)([O-])OP(=O)([O-])[O-])O)O)N=C(NC2=O)N.[Na+].[Na+].[Na+]InChIKey: KZRMTEVIDYXWQW-CYCLDIHTSA-KInChI: InChI=1S/C10H16N5O14P3.3Na/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21;;;/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18);;;/q;3*+1/p-3/t3-,5-,6-,9-;;;/m1.../s1Synonyms: guanosine 5'-tri-phosphate sodium salt Solution | Guanosine-5'-triphosphate sodium salt Solution | 5'-GTP trisodium s...
-
N1-Me-Pseudo UTP Trisodium solutionCas#: 1428903-59-6(free acid) Compound CID: 90456815Formula: C10H14N2Na3O15P3 Molecular Weight: 564.11IUPAC Name: [[(2R,3S,4R,5S)-3,4-dihydroxy-5-(1-methyl-2,4-dioxopyrimidin-5-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphateSMILES: CN1C=C(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)OInChIKey: OLRONOIBERDKRE-XUTVFYLZSA-NInChI: InChI=1S/C10H17N2O15P3/c1-12-2-4(9(15)11-10(12)16)8-7(14)6(13)5(25-8)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h2,5-8,13-14H,3H2,1H3,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t5-,6-,7-,8+/m1/s1Synonyms: N1-.Pseudo.utp|n1-methylpseudouridine-5'-triphosphate|1428903-59-6|5ENC36P33M|1-Methylpseudouridine-5'-triphosphate|N...
-
Pseudo UTP Trisodium solutionCas#: 1175-34-4(free acid)Formula: C9H12N2Na3O15P3 Molecular Weight: 550.08
-
UTP Trisodium salt SolutionCas#: 19817-92-6Formula: C9H12N2Na3O15P3· xH2O Molecular Weight: 550.09 (anhydrous basis)IUPAC Name: trisodium;[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphateSMILES: [Na+].[Na+].[Na+].O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)N2C=CC(=O)NC2=OInChIKey: MMJGIWFJVDOPJF-LLWADOMFSA-KInChI: InChI=1S/C9H15N2O15P3.3Na/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18;;;/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18);;;/q;3*+1/p-3/t4-,6-,7-,8-;;;/m1.../s1Synonyms: 19817-92-6|uridine-5'-triphosphoric acid trisodium salt|Uridine 5'-triphosphate sodium|Uridine 5'-Triphosphate Trisod...
